Terms: = Germ cell tumor AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
57 results:
1. Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.
Noviello TMR; Di Giacomo AM; Caruso FP; Covre A; Mortarini R; Scala G; Costa MC; Coral S; Fridman WH; Sautès-Fridman C; Brich S; Pruneri G; Simonetti E; Lofiego MF; Tufano R; Bedognetti D; Anichini A; Maio M; Ceccarelli M
Nat Commun; 2023 Sep; 14(1):5914. PubMed ID: 37739939
[TBL] [Abstract] [Full Text] [Related]
2. A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.
Marsiglio J; McPherson JP; Kovacsovics-Bankowski M; Jeter J; Vaklavas C; Swami U; Grossmann D; Erickson-Wayman A; Soares HP; Kerrigan K; Gibson B; Doherty JA; Hyngstrom J; Hardikar S; Hu-Lieskovan S
Front Immunol; 2023; 14():1229823. PubMed ID: 37671166
[TBL] [Abstract] [Full Text] [Related]
3. Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.
Zhang H; Jiang D; Meng E; Zhao M; Niu B
Immunotherapy; 2023 Jan; 15(1):17-25. PubMed ID: 36647794
[TBL] [Abstract] [Full Text] [Related]
4. HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade.
Shao XM; Huang J; Niknafs N; Balan A; Cherry C; White J; Velculescu VE; Anagnostou V; Karchin R
Ann Oncol; 2022 Jul; 33(7):728-738. PubMed ID: 35339648
[TBL] [Abstract] [Full Text] [Related]
5. Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors.
Mantia CM; Werner L; Stwalley B; Ritchings C; Tarhini AA; Atkins MB; McDermott DF; Regan MM
Melanoma Res; 2022 Feb; 32(1):35-44. PubMed ID: 34855329
[TBL] [Abstract] [Full Text] [Related]
6. Somatic-type Malignancies in Testicular germ cell tumors: A Clinicopathologic Study of 63 Cases.
Hwang MJ; Hamza A; Zhang M; Tu SM; Pisters LL; Czerniak B; Guo CC
Am J Surg Pathol; 2022 Jan; 46(1):11-17. PubMed ID: 34334690
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study.
Lehrich BM; Goshtasbi K; Hsu FPK; Kuan EC
Childs Nerv Syst; 2021 May; 37(5):1535-1545. PubMed ID: 33641032
[TBL] [Abstract] [Full Text] [Related]
8. Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma.
Robert C; Hwu WJ; Hamid O; Ribas A; Weber JS; Daud AI; Hodi FS; Wolchok JD; Mitchell TC; Hersey P; Dronca R; Joseph RW; Boutros C; Min L; Long GV; Schachter J; Puzanov I; Dummer R; Lin J; Ibrahim N; Diede SJ; Carlino MS; Joshua AM
Eur J Cancer; 2021 Feb; 144():182-191. PubMed ID: 33360855
[TBL] [Abstract] [Full Text] [Related]
9. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.
Goldberg JL; Navid F; Hank JA; Erbe AK; Santana V; Gan J; de Bie F; Javaid AM; Hoefges A; Merdler M; Carmichael L; Kim K; Bishop MW; Meager MM; Gillies SD; Pandey JP; Sondel PM
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169872
[TBL] [Abstract] [Full Text] [Related]
10. Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN).
Chan Wah Hak C; Coyle C; Kocache A; Short D; Sarwar N; Seckl MJ; Gonzalez MA
BMC Cancer; 2019 Aug; 19(1):770. PubMed ID: 31382912
[TBL] [Abstract] [Full Text] [Related]
11. Catheter guided cerebral glioma resection combined with awake craniotomy: its usefulness and surgical outcome.
Bunyaratavej K; Wangsawatwong P
Br J Neurosurg; 2019 Oct; 33(5):528-535. PubMed ID: 30860928
[No Abstract] [Full Text] [Related]
12. Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.
Verma G; Chawla S; Mohan S; Wang S; Nasrallah M; Sheriff S; Desai A; Brem S; O'Rourke DM; Wolf RL; Maudsley AA; Poptani H
NMR Biomed; 2019 Feb; 32(2):e4042. PubMed ID: 30556932
[TBL] [Abstract] [Full Text] [Related]
13. Biomarkers Associated with clinical outcome of Advanced Melanoma Patients Treated with Ipilimumab.
Balatoni T; Ladányi A; Fröhlich G; Czirbesz K; Kovács P; Pánczél G; Bence E; Plótár V; Liszkay G
Pathol Oncol Res; 2020 Jan; 26(1):317-325. PubMed ID: 30225783
[TBL] [Abstract] [Full Text] [Related]
14. Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.
Retseck J; Nasr A; Lin Y; Lin H; Mendiratta P; Butterfield LH; Tarhini AA
J Transl Med; 2018 Jul; 16(1):184. PubMed ID: 29973204
[TBL] [Abstract] [Full Text] [Related]
15. Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict clinical outcome.
Forget MA; Haymaker C; Hess KR; Meng YJ; Creasy C; Karpinets T; Fulbright OJ; Roszik J; Woodman SE; Kim YU; Sakellariou-Thompson D; Bhatta A; Wahl A; Flores E; Thorsen ST; Tavera RJ; Ramachandran R; Gonzalez AM; Toth CL; Wardell S; Mansaray R; Patel V; Carpio DJ; Vaughn C; Farinas CM; Velasquez PG; Hwu WJ; Patel SP; Davies MA; Diab A; Glitza IC; Tawbi H; Wong MK; Cain S; Ross MI; Lee JE; Gershenwald JE; Lucci A; Royal R; Cormier JN; Wargo JA; Radvanyi LG; Torres-Cabala CA; Beroukhim R; Hwu P; Amaria RN; Bernatchez C
Clin Cancer Res; 2018 Sep; 24(18):4416-4428. PubMed ID: 29848573
[No Abstract] [Full Text] [Related]
16. The difficulty of predicting clinical outcome after intended submaximal resection of large vestibular Schwannomas.
MacKenzie R; Sporns P; Zoubi T; Koopmann M; Ewelt C; Stummer W; Brokinkel B; Suero Molina E
J Clin Neurosci; 2018 Apr; 50():62-68. PubMed ID: 29429787
[TBL] [Abstract] [Full Text] [Related]
17. tumor-Infiltrating Merkel cell Polyomavirus-Specific T cells Are Diverse and Associated with Improved Patient Survival.
Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
[TBL] [Abstract] [Full Text] [Related]
18. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933
[TBL] [Abstract] [Full Text] [Related]
19. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.
Tu SM; Bilen MA; Hess KR; Broaddus RR; Kopetz S; Wei C; Pagliaro LC; Karam JA; Ward JF; Wood CG; Rao P; Tu ZH; General R; Chen AH; Nieto YL; Yeung SC; Lin SH; Logothetis CJ; Pisters LL
Cancer; 2016 Jun; 122(12):1836-43. PubMed ID: 27018785
[TBL] [Abstract] [Full Text] [Related]
20. Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-Up.
Bertelli E; Leonini S; Galimberti D; Moretti S; Tinturini R; Hadjistilianou T; De Francesco S; Romano DG; Vallone IM; Cioni S; Gennari P; Galluzzi P; Grazzini I; Rossi S; Bracco S
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1289-95. PubMed ID: 26915566
[TBL] [Abstract] [Full Text] [Related]
[Next]
